arrow
G

Gabriel G. Malouf

cnrs and inserm and unistra
H指数:40
被引数:5,429

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MiT fusions, TSC1–TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa

MiT融合、TSC1–TSC2分化以及干细胞样程序揭示PEComa的不同起源和脆弱性

2026-06-230
OAAI
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study

Tazemetostat,一种EZH2抑制剂,在携带SWI/SNF突变的实体瘤中的II期篮式研究

2026-03-250
OAAI
Normal organ [68Ga]DOTATOC uptake during PRRT: challenging the assumption of stable background shaped by cold somatostatin analogues treatment

正常器官[⁶⁸Ga]DOTATOC摄取在PRRT期间:挑战由冷生长抑素类似物治疗形成的稳定背景的假设

2025-11-150
PRE
Racial differences in kidney cancer histology and outcome: A nationwide study from the UroCCR Cohort

肾癌组织学特征与预后的种族差异:一项来自UroCCR队列的全国性研究

Cancer
IF5.1
2025-10-080
OAAI
Prospective Analysis of Mesotheliomas in Subjects with BAP1 Cancer Syndrome: Clinical Characteristics and Epigenetic Correlates of Disease

BAP1癌症综合征患者中胸膜瘤的前瞻性分析:疾病临床特征与表观遗传相关性

2025-08-060
PREAI
EGFR-Mutant Urothelial Carcinoma Harboring an Ala750_Ile759delinsGlyGly Alteration with a Primary Resistance to Polychemotherapy and a Sensitivity to Osimertinib: A Literature Review on EGFR Alterations and Response to EGFR Tyrosine Kinase Inhibitors in Cancers

EGFR突变型尿路上皮癌携带Ala750_Ile759delinsGlyGly改变,对多药化疗原发耐药且对Osimertinib敏感:关于EGFR改变及癌症对EGFR酪氨酸激酶抑制剂反应的文献综述

2025-04-300
OA
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma

TFE3融合驱动移位性肾细胞癌中的氧化代谢和铁死亡抵抗

2025-03-270
OA
PEC-PRO: A new prognostic score from a series of 87 patients with localized perivascular epithelioid cell neoplasms (PEComas) treated with curative intent
CANCER
IF5.1
2024-03-122
OAAI
Mesenchymal-like Tumor Cells and Myofibroblastic Cancer-Associated Fibroblasts Are Associated with Progression and Immunotherapy Response of Clear Cell Renal Cell Carcinoma
2023-06-1914
PRE
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance
2023-05-2613
OAAI
Roles of mesenchymal-like tumour cells and myofibroblastic cancer-associated fibroblasts in progression and therapeutic response of clear-cell renal cell carcinoma
2023-04-041
PRE